Written Question·Department of Health and Social Care·UIN 69602

Obesity: Drugs

Tabled: 21 July 2025
Answered: 1 September 2025

Question

Mr Andrew Snowden

Conservative — Fylde

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 July 2025 to Question 67568 on Obesity: Drugs, whether his Department has issued any guidance to the public on the risks of obtaining weight loss medications through on

Answer

Karin Smyth
The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors the safety of all medicines, including weight loss drugs such as GLP-1 receptor agonists (GLP-1 RAs).Patient safety is our top priority, and no medicine would be approved ...
ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 69602) →